- Home
- CR vs RVTY Comparison
CR vs RVTY Comparison
Compare CR & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CR | RVTY |
|---|---|---|
| Founded | 1855 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.6B | 11.6B |
| IPO Year | 2022 | 1994 |
Fundamental Metrics
Financial Performance| Metric | CR | RVTY |
|---|---|---|
| Price | $218.97 | $109.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 16 |
| Target Price | ★ $226.20 | $109.67 |
| AVG Volume (30 Days) | 377.9K | ★ 1.4M |
| Earning Date | 04-27-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.58% | 0.34% |
| EPS Growth | ★ 23.96 | N/A |
| EPS | ★ 1.14 | 0.36 |
| Revenue | $2,305,000,000.00 | ★ $3,311,822,000.00 |
| Revenue This Year | $27.98 | $6.37 |
| Revenue Next Year | $5.76 | $5.10 |
| P/E Ratio | ★ $190.82 | $295.67 |
| Revenue Growth | ★ 8.16 | N/A |
| 52 Week Low | $159.58 | $81.22 |
| 52 Week High | $226.46 | $118.30 |
Technical Indicators
Market Signals| Indicator | CR | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 60.52 | 54.05 |
| Support Level | $211.62 | $108.02 |
| Resistance Level | $226.46 | $117.23 |
| Average True Range (ATR) | 6.47 | 3.30 |
| MACD | -1.23 | -0.81 |
| Stochastic Oscillator | 56.68 | 62.07 |
Price Performance
Historical ComparisonAbout CR Crane Company
Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and advanced technologies, and process flow technologies. Crane generated approximately $2.3 billion in revenue in 2025.
About RVTY Revvity Inc.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.